FCI
IRWD icon

Financial Counselors Inc’s Ironwood Pharmaceuticals IRWD Stock Holding History

Financial Counselors Inc’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-10,660
Closed -$134K – 524
2022
Q1 		$134K Buy
10,660
+590
+6% +$6.76K ﹤0.01% 508
2021
Q4 		$117K Buy
+10,070
New +$124K ﹤0.01% 510
2021
Q1 		– Sell
-14,100
Closed -$161K – 536
2020
Q4 		$161K Hold
14,100
– – ﹤0.01% 518
2020
Q3 		$127K Buy
14,100
+1,700
+14% +$16.9K ﹤0.01% 489
2020
Q2 		$128K Sell
12,400
-10,020
-45% -$103K ﹤0.01% 501
2020
Q1 		$226K Buy
22,420
+5,460
+32% +$64.2K 0.01% 403
2019
Q4 		$226K Buy
16,960
+400
+2% +$4.41K 0.01% 492
2019
Q3 		$142K Buy
16,560
+650
+4% +$6.32K 0.01% 523
2019
Q2 		$174K Sell
15,910
-2,119
-12% -$23.7K 0.01% 504
2019
Q1 		$204K Buy
+18,029
New +$201K 0.01% 492

Other funds holding IRWD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Sarissa Capital Management Greenwich, Connecticut $158M AUM 103.7% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Financial Counselors Inc's IRWD Position: Q2 2022 in Review

Financial Counselors Inc sold out of Ironwood Pharmaceuticals (IRWD) in Q2 2022, closing a stake of 10,660 shares — an estimated $134K sold.

Financial Counselors Inc first reported a position in IRWD in Q1 2019 and held it in 10 quarters. The position peaked at $226K in Q1 2020. 239 funds tracked by Wall St. Rank hold IRWD as of Q2 2022.

  • Financial Counselors Inc reported no remaining Ironwood Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Financial Counselors Inc sold 10,660 Ironwood Pharmaceuticals shares in Q2 2022, an estimated $134K.
  • Financial Counselors Inc first reported a position in Ironwood Pharmaceuticals in Q1 2019 and held it in 10 quarters.
  • Financial Counselors Inc's Ironwood Pharmaceuticals position peaked at $226K in Q1 2020.
  • 239 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q2 2022.

Based on Financial Counselors Inc's 13F filing for Q2 2022, filed 2 Aug 2022.